MedPath

Study on the safety and efficacy of the ketogenic diets for stage IV advanced and recurrent cancer patients.

Phase 1
Conditions
All types of cancer for which PET-CT examination is indicated
Registration Number
JPRN-UMIN000039925
Lead Sponsor
Tama-Nanbu Regional Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation Department of Surgery
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Cachexia patients

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath